NASDAQ:TWST Twist Bioscience (TWST) Stock Price, News & Analysis $103.23 -8.39 (-7.51%) Closing price 03:58 PM EasternExtended Trading$104.01 +0.78 (+0.75%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Twist Bioscience Stock (NASDAQ:TWST) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Twist Bioscience alerts:Sign Up Key Stats Today's Range$101.00▼$108.5050-Day Range$103.23▼$205.0052-Week Range$25.67▼$219.71Volume3.38 million shsAverage Volume2.48 million shsMarket Capitalization$6.47 billionP/E RatioN/ADividend YieldN/APrice Target$133.92Consensus RatingHold Company Overview Twist Bioscience Corporation is a biotechnology company that uses a silicon-based platform to manufacture synthetic DNA. Its technology supports the production of many DNA sequences in parallel for research and commercial applications. The company provides synthetic genes, gene fragments and oligonucleotide pools, as well as tools for next-generation sequencing, including target-enrichment products. Through its biopharma business, Twist also offers antibody discovery and related services to support the development of therapeutics. Founded in 2013 and headquartered in South San Francisco, California, Twist serves customers in biotechnology, pharmaceutical, academic, agricultural and other industries around the world. Co-founder Emily Leproust serves as the company’s chief executive officer.AI Generated. May Contain Errors. Read More Twist Bioscience Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks56th Percentile Overall ScoreTWST MarketRank™: 2.820936639115 of 5 starsTwist Bioscience scored higher than 56% of companies evaluated by MarketBeat, and ranked 482nd out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.2 / 5Analyst RatingHold Consensus RatingTwist Bioscience has received a consensus rating of Hold. The company's average rating score is 2.42, and is based on no strong buy ratings, 7 buy ratings, 3 hold ratings, and 2 sell ratings.Upside PotentialTwist Bioscience has a consensus price target of $133.92, representing about 29.7% upside from its current price of $103.23.Amount of Analyst CoverageTwist Bioscience has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Twist Bioscience's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Twist Bioscience are expected to grow in the coming year, from ($1.42) to ($1.19) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Twist Bioscience is -49.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Twist Bioscience is -49.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTwist Bioscience has a P/B Ratio of 7.29. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Twist Bioscience's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted16.18% of the float of Twist Bioscience has been sold short.Short Interest Ratio / Days to CoverTwist Bioscience has a short interest ratio ("days to cover") of 4.35.Change versus previous monthShort interest in Twist Bioscience has recently decreased by 3.64%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTwist Bioscience does not currently pay a dividend.Dividend GrowthTwist Bioscience does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment0.14 News SentimentTwist Bioscience has a news sentiment score of 0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.42 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 16 news articles for Twist Bioscience this week, compared to 6 articles on an average week.Search InterestOnly 9 people have searched for TWST on MarketBeat in the last 30 days. This is a decrease of -53% compared to the previous 30 days.MarketBeat Follows7 people have added Twist Bioscience to their MarketBeat watchlist in the last 30 days. This is an increase of 40% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Twist Bioscience insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $80,489,387.00 in company stock.Percentage Held by Insiders3.08% of the stock of Twist Bioscience is held by insiders.Percentage Held by InstitutionsTwist Bioscience has minimal institutional ownership at this time.Read more about Twist Bioscience's insider trading history. Receive TWST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Twist Bioscience and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TWST Stock News HeadlinesTwist Bioscience (TWST) Stock Looks Pricey Next To Its Sales Growth StoryNovember 19 at 1:50 PM | uk.finance.yahoo.comTwist Bioscience (TWST) Posted Higher Revenue And A Narrower Loss, Is It Still 31% Undervalued?November 19 at 1:50 PM | finance.yahoo.comURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards urges homeowners to check the map and see whether one is near them. Families in Georgia have been forced to sell, entire Ohio neighborhoods are being torn down, and nearly 50,000 Lake Tahoe residents face losing power. Rickards advised the Pentagon and the U.S. intelligence community for decades. He says one man outside Washington can stop it.November 20 at 1:00 AM | Paradigm Press (Ad)Twist Bioscience (NASDAQ:TWST) Stock Price Target Cut by BarclaysNovember 18 at 2:00 AM | americanbankingnews.comAnalysts Are Bullish on Top Healthcare Stocks: Twist Bioscience (TWST), Ascendis Pharma (ASND)November 17 at 8:04 AM | theglobeandmail.comTwist Bioscience Earnings Call Signals Strong Growth AheadNovember 17 at 8:04 AM | theglobeandmail.comTwist Bioscience: Long-Term 'Buy' On AI Discovery For BiotechNovember 16, 2026 | seekingalpha.comTwist Bioscience (NASDAQ:TWST) CAO Robert Werner Sells 148 Shares of Company StockNovember 6, 2026 | insidertrades.comSee More Headlines TWST Stock Analysis - Frequently Asked Questions How have TWST shares performed this year? Twist Bioscience's stock was trading at $31.72 at the beginning of 2026. Since then, TWST shares have increased by 225.5% and is now trading at $103.2330. How were Twist Bioscience's earnings last quarter? Twist Bioscience Corporation (NASDAQ:TWST) posted its quarterly earnings data on Thursday, November, 12th. The company reported ($0.32) EPS for the quarter, topping the consensus estimate of ($0.39) by $0.07. Twist Bioscience's revenue for the quarter was up 26.7% on a year-over-year basis. Read the conference call transcript. When did Twist Bioscience IPO? Twist Bioscience (TWST) raised $75 million in an initial public offering (IPO) on Wednesday, October 31st 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Cowen served as the underwriters for the IPO and Allen & Company and Baird were co-managers. Who are Twist Bioscience's major shareholders? Top institutional shareholders of Twist Bioscience include State Street Corp (4.81%), Goldman Sachs Group Inc. (2.73%), William Blair Investment Management LLC (2.32%) and Stephens Investment Management Group LLC (1.24%). Insiders that own company stock include Emily M Leproust, William Banyai, Patrick John Finn, Paula Green, Adam Laponis, Dennis Cho, Robert F Werner, Melissa A Starovasnik, Robert Chess and Jan Johannessen. View institutional ownership trends. How do I buy shares of Twist Bioscience? Shares of TWST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Twist Bioscience own? Based on aggregate information from My MarketBeat watchlists, some other companies that Twist Bioscience investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), CrowdStrike (CRWD), CRISPR Therapeutics (CRSP), Palantir Technologies (PLTR) and Block (XYZ). Company Calendar Last Earnings11/12/2026Today11/20/20269th Annual Evercore ISI HealthCONx Conference12/01/2026Next Earnings (Estimated)2/01/2027Fiscal Year End9/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 2 weeks, TWST's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:TWST CIK1581280 Webwww.twistbioscience.com Phone(800) 719-0671FaxN/AEmployees979Year Founded2013Price Target and Rating Average Price Target for Twist Bioscience$133.92 High Price Target$212.00 Low Price Target$45.00 Potential Upside/Downside+29.7%Consensus RatingHold Rating Score (0-4)2.42 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)($2.09) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$130.20 million Net Margins-28.34% Pretax Margin-31.46% Return on Equity-27.53% Return on Assets-18.80% Debt Debt-to-Equity Ratio0.03 Current Ratio2.67 Quick Ratio2.38 Sales & Book Value Annual Sales$459.43 million Price / Sales14.09 Cash FlowN/A Price / Cash FlowN/A Book Value$7.84 per share Price / Book13.17Miscellaneous Outstanding Shares62,710,000Free Float60,776,000Market Cap$6.47 billion OptionableOptionable Beta2.25 Social Links 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report This page (NASDAQ:TWST) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredA $4,120 Caterpillar winner in 2 days, now $7 for Black FridayMarkham Trading's Alpha Oracle Signal system is just $7 for Black Friday. Others paid nearly $2,000 for access...TradeWins | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.